Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-12 McFarlane Neil F. President and CEO Sale 10b5-1 −20,000 $11.25 $225K 417,225
2026-10-10 McFarlane Neil F. President and CEO Option exercise 10b5-1 +50,000 437,225
2026-10-10 McFarlane Neil F. President and CEO Option exercise · Restricted Stock Unit 10b5-1 −50,000 50,000
2026-08-14 Thompson Rahsaan Chief Legal & Compliance Sale 10b5-1 −42,666 $11.13 $475K 37,569
2026-08-10 Watton Corey Michael Director Option exercise +12,300 $4.97 $61K 14,100
2026-08-10 Watton Corey Michael Director Sale −12,300 $11.25 $138K 1,800
2026-08-10 Watton Corey Michael Director Option exercise · Stock Option (right to buy) −12,300 46,500
2026-06-22 Thompson Rahsaan Chief Legal & Compliance Sale 10b5-1 −34,557 $12.68 $438K 80,235
2026-06-21 Thompson Rahsaan Chief Legal & Compliance Option exercise 10b5-1 +66,667 114,792
2026-06-21 Thompson Rahsaan Chief Legal & Compliance Option exercise · Restricted Stock Unit 10b5-1 −66,667 66,667
2026-06-04 FAVORITO TAMARA A Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-06-04 Secor Alicia Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-06-04 Watton Corey Michael Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-06-04 Calder Douglas W Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-06-04 Anderson Thomas Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-06-04 Shih Alvin Director Grant or award · Stock Option (right to buy) +30,000 30,000
2026-05-28 Sangiovanni Timothy J. SVP, Finance & Corp Controller Grant or award · Stock Option (right to buy) +40,000 40,000
2026-05-28 Sangiovanni Timothy J. SVP, Finance & Corp Controller Grant or award · Restricted Stock Unit +20,000 20,000
2026-05-11 Thompson Rahsaan Chief Legal & Compliance Sale 10b5-1 −1,794 $11.30 $20K 48,125
2026-03-24 Bode John B Director Option exercise +39,200 $4.97 $195K 84,200

Page 1 of 16 · 319 trades